Introduction {#aos13527-sec-0005}
============

Optic disc pit (ODP) is a developmental defect in the optic nerve head, consisting of a round or oval depression in the neuroretinal rim, most frequently located temporally (Brown et al. [1980](#aos13527-bib-0005){ref-type="ref"}; Georgalas et al. [2011](#aos13527-bib-0008){ref-type="ref"}). Clinically, the condition can be asymptomatic, but a decrease in VA can arise from cystoid macular oedema, retinoschisis (RS) or a serous detachment of the retina (Gass [1969](#aos13527-bib-0007){ref-type="ref"}; Lincoff et al. [1988](#aos13527-bib-0015){ref-type="ref"}; Trichonas & Kaiser [2014](#aos13527-bib-0024){ref-type="ref"}).

Several publications have described successful management through different, predominately surgical approaches such as laser photocoagulation, macular buckling, PPV, with or without laser photocoagulation, ILM peeling and vitreous gas tamponade (Annesley et al. [1987](#aos13527-bib-0001){ref-type="ref"}; Theodossiadis & Theodossiadis [2000](#aos13527-bib-0022){ref-type="ref"}; Hirakata et al. [2005](#aos13527-bib-0009){ref-type="ref"}, [2012](#aos13527-bib-0010){ref-type="ref"}; Rizzo et al. [2012](#aos13527-bib-0020){ref-type="ref"}). The exact pathophysiology, however, remains unknown. The retinal structure often has an appearance similar to the one seen in RS (Theodossiadis & Theodossiadis [2000](#aos13527-bib-0022){ref-type="ref"}; Lalwani et al. [2007](#aos13527-bib-0014){ref-type="ref"}; Imamura et al. [2010](#aos13527-bib-0011){ref-type="ref"}; Hirakata et al. [2012](#aos13527-bib-0010){ref-type="ref"}) and can lead to permanent loss of vision and the development of a macular hole, especially if the duration of SRF has been long (Sobol et al. [1990](#aos13527-bib-0021){ref-type="ref"}; Bonnet [1991](#aos13527-bib-0004){ref-type="ref"}).

The exact pathophysiological mechanisms for the development of subretinal and intraretinal fluid are unknown. Most likely, however, these findings originate either from a direct communication between the ODP and the subarachnoid space or that the unnaturally strong attachment between the posterior hyaloid at the site of the ODP allows fluid to leakage into or through the retina (Johnson & Johnson [2004](#aos13527-bib-0013){ref-type="ref"}; Jain & Johnson [2014](#aos13527-bib-0012){ref-type="ref"}).

Beta‐trace protein (*β*TP) is a molecule used for confirming the presence of CSF leakage into the nasal cavity due to its relatively high concentration in CSF. It is also found in, for example, perilymph, serum, urine, amniotic fluid and central nervous system (CNS) (Melegos et al. [1996](#aos13527-bib-0017){ref-type="ref"}; Tumani et al. [1998](#aos13527-bib-0025){ref-type="ref"}). Also, *β*TP levels are high in retina, interphotoreceptor matrix and retinal pigment epithelial (RPE) cells, possibly being both an enzymatically active molecule as well as carrying out intercellular transport between RPE and photoreceptor cells (Beuckmann et al. [1996](#aos13527-bib-0003){ref-type="ref"}). We wanted to investigate if the subretinal optic pit fluid originates from CSF or not, using *β*TP as a biomarker of CSF. We here report our findings in a consecutive series of four patients.

Materials and Methods {#aos13527-sec-0006}
=====================

The study adhered to the tenets of the declaration of Helsinki and involved treatment and follow‐up of four patients with diagnosed ODP, including a macular detachment. Approval for the study was given by the regional review board, and a written informed consent was collected from all included subjects. The patients were referred to the Department of Ophthalmology, Örebro University Hospital. Preoperatively, the clinical diagnosis was confirmed by slit‐lamp examination by a vitreoretinal surgeon and macular detachment was further evaluated by optical coherence tomography (OCT) examination. All patients were otherwise healthy with no prior history of ocular disease. Information about age, gender and OCT findings is shown in Table [1](#aos13527-tbl-0001){ref-type="table-wrap"}. Only patients with a follow‐up time exceeding 1 year after the initial operation were included in the study.

###### 

Specific information on patient characteristics, OCT findings and gauge size of aspiration needle used for sampling of SRF

  Patient number   Age at surgery   Sex      Eye     Aspiration needle size   OCT findings
  ---------------- ---------------- -------- ------- ------------------------ ---------------
  1                50               Male     Left    42 gauge                 SRF + RS
  2                13               Female   Left    39 gauge                 SRF
  3                21               Female   Right   39 gauge                 SRF + RS + MH
  4                60               Female   Left    30 gauge                 SRF

SRF= Subretinal fluid, RS= Retinoschisis, MH= Full‐thickness macular hole, OCT = optical coherence tomography.
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The patients were all operated with PPV, peeling of the ILM and vitreous gas tamponade with C~2~F~6~ between April 2012 and June 2014. During the procedure, after the ILM peeling, SRF was aspirated by placing a fine cannula (gauge size specified in Table [1](#aos13527-tbl-0001){ref-type="table-wrap"}) through the retina superior to the macular region, within temporal the vascular arcades. No photocoagulation treatment was done after drainage. Subsequently, the small fluid volume was transferred into the bottom of an Eppendorf tube that had been preweighed on a high‐resolution balance (Sartorius Cubis MSA, Sartorius AG, Göttingen, FRG). Thereafter, the tube was rapidly taken to the laboratory, weighed again, and the change in weight was considered to be a measure of the volume of the aspirated fluid, under the assumption that 1 mg of SRF ≈ 1 *μ*l. From the initial weighing, the tubes were kept in sealed plastic bags and care was taken not to touch them, except by sterile instruments. Values around 3 *μ*l were typically obtained. Samples were then diluted with reagent buffer sufficiently to fill the minimum requirement of the analytical instrument (50 *μ*l). Assay of *β*‐trace protein was performed by particle‐enhancing nephelometry using the reagent kit "N Latex *β* TP" (Siemens, Marburg, FRG) on a BN Prospec® nephelometer (Dade Behring, Marburg, FRG). The measuring range was 0.25--16 mg/l and the coefficient of variation 8%. To get a picture of the typical CSF levels, we also analysed *β*TP concentrations in 20 consecutive de‐identified CSF samples sent to our routine laboratory for CSF protein isoelectric focusing analysis. Resolution of SRF after vitrectomy was slow in all patients.

###### 

Data on follow‐up time (in months), visual acuity (VA) before surgery as well as at the latest control visit and beta‐trace protein (*β*TP) concentration in SRF

  Patient number   Follow‐up time   Preop VA   Postop VA   *β*TP in SRF (mg/l)
  ---------------- ---------------- ---------- ----------- ---------------------
  1                43               0.2        0.62        2.0
  2                32               0.77       0.77        2.4
  3                20               0.2        0.5         2.5
  4                28               0.5        0.31        23.1/2.8
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Results {#aos13527-sec-0007}
=======

Complete regression of fluid in the macular region occurred in all patients and the end of the follow‐up period. However, one patient had to undergo the surgery twice. Visual acuity (VA) before surgery and at the end of follow‐up period is specified in Table [2](#aos13527-tbl-0002){ref-type="table-wrap"}. It improved in two and worsened in one of the four operated eyes.

Patient 1 {#aos13527-sec-0008}
---------

Preoperatively, OCT showed a pronounced RS with a retinal detachment involving the macula (Fig. [1](#aos13527-fig-0001){ref-type="fig"}). After the surgery, the SRF level, RS and VA were improved; however, resolution of the macular detachment was delayed with a gradual disappearance of SRF (Fig. [2](#aos13527-fig-0002){ref-type="fig"}). At the latest visit, the retina was reattached without SRF or RS (Fig. [3](#aos13527-fig-0003){ref-type="fig"}).

![Spectral domain optical coherence tomography picture of patient 1 the day before surgery. The intraretinal fluid is more accentuated towards the optic disc, and the macular elevation due to subretinal fluid is high.](AOS-95-815-g001){#aos13527-fig-0001}

![Two months postoperatively, the retinal structure is still thickened, but the fluid under the macula has decreased.](AOS-95-815-g002){#aos13527-fig-0002}

![At the end of the follow‐up period, 43 months after vitrectomy, the retinal structure has normalized and no subretinal fluid remains.](AOS-95-815-g003){#aos13527-fig-0003}

Patient 2 {#aos13527-sec-0009}
---------

In this patient, the SRF regressed adequately after the surgery (Figs [4](#aos13527-fig-0004){ref-type="fig"} and [5](#aos13527-fig-0005){ref-type="fig"}); however, VA did not change during the study period.

![Preoperative optical coherence tomography image the day prior to vitrectomy of patient 2 shows a serous detachment without retinoschisis.](AOS-95-815-g004){#aos13527-fig-0004}

![Optical coherence tomography of the macular region at the latest examination, 32 months postoperatively, without subretinal fluid.](AOS-95-815-g005){#aos13527-fig-0005}

Patient 3 {#aos13527-sec-0010}
---------

Optical coherence tomography (OCT) examination before surgery confirmed a full‐thickness macular hole as well as a RS in the affected eye (Fig. [6](#aos13527-fig-0006){ref-type="fig"}). During the operation, a retinal tear developed, when posterior vitreous detachment was induced. Treatment with laser photocoagulation was conducted preoperatively and, as in all other cases, a vitreous gas tamponade was given. No rhegmatogenous retinal detachment developed. The macular hole closed and the intraretinal oedema disappeared, but as in patient 1, complete regression of the SRF involving the macular region disappeared gradually during the follow‐up period (Figs [7](#aos13527-fig-0007){ref-type="fig"}, [8](#aos13527-fig-0008){ref-type="fig"}).

![Preoperative optical coherence tomography picture of patient 3 on the day of pars plana vitrectomy shows a marked retinoschisis, predominately in the outer plexiform layer, and a full‐thickness macular hole.](AOS-95-815-g006){#aos13527-fig-0006}

![Nine months postoperatively, a resolution of the most of the intraretinal fluid has occurred with healing of the macular hole, but a small subretinal fluid level is still seen.](AOS-95-815-g007){#aos13527-fig-0007}

![At the latest visit, 20 months after vitrectomy, minor defects are observed at the photoreceptor layer, in the foveal region, but there is no level of subretinal fluid.](AOS-95-815-g008){#aos13527-fig-0008}

Patient 4 {#aos13527-sec-0011}
---------

After surgery, due to a macular detachment without RS (Fig. [9](#aos13527-fig-0009){ref-type="fig"}), there was a tendency towards a decrease in SRF level, but after 9 months the retinal detachment involving the macula was higher than before surgery (Fig. [10](#aos13527-fig-0010){ref-type="fig"}), why a new PPV procedure was scheduled. Again, drainage using a 30‐gauge cannula and sampling of SRF for *β*TP was done and 16 per cent C~2~F~6~ vitreous gas tamponade was given. The macula was reattached and regression of SRF occurred. Twelve months after the second procedure, phacoemulsification was conducted and at latest examination, 17 months after the second vitrectomy, only traces of SRF remained outside the macular region (Fig. [11](#aos13527-fig-0011){ref-type="fig"}).

![In patient 4 the day before vitrectomy, optical coherence tomography shows a detached macula without retinoschisis.](AOS-95-815-g009){#aos13527-fig-0009}

![After an initial improvement, optical coherence tomography image, 9 months postoperatively, depicts high detachment involving the fovea.](AOS-95-815-g010){#aos13527-fig-0010}

![The central macula is reattached, 28 months after the initial pars plana vitrectomy.](AOS-95-815-g011){#aos13527-fig-0011}

Beta‐trace protein concentrations in SRF and CSF {#aos13527-sec-0012}
------------------------------------------------

The analysed subretinal aspirate had a mean *β*TP concentration of 6.6 mg/l (range 2.0--23.1 mg/l). These values for each patient are specified in Table [2](#aos13527-tbl-0002){ref-type="table-wrap"}. The only test within the range corresponding to normal CSF was the first sample from patient 4, who underwent two operations due to deterioration in VA and SRF. However, the analysis done from the aspirate during the second operation was 2.8 mg/l. In a series of consecutive CSF samples sent to our routine laboratory, the mean *β*TP concentration was 16.0 mg/l (range 6.3--26.8 mg/l).

Discussion {#aos13527-sec-0013}
==========

In this report, we describe a technique to analyse the levels of *β*TP found in the subretinal space during PPV to try to validate if the levels are equal to those found in CSF. The results in these four patients are not entirely conclusive. The *β*TP concentrations from three of them were considerably lower than those normally found in CSF, but the first sample from the fourth patient was within the interval typically found in CSF. This is to our knowledge the first published work where the SRF from humans has been extracted and analysed regarding presence of CSF proteins in ODP.

The pathogenesis in ODP is still not fully understood, but several articles have emphasized posterior vitreous traction on the pit and an abnormally strong vitreoretinal interface as principal features for development of the RS‐like retinal structure as well as the development of the macular detachment (Brown et al. [1980](#aos13527-bib-0005){ref-type="ref"}; Johnson & Johnson [2004](#aos13527-bib-0013){ref-type="ref"}; Theodossiadis et al. [2007](#aos13527-bib-0023){ref-type="ref"}; Hirakata et al. [2012](#aos13527-bib-0010){ref-type="ref"}; Ooto et al. [2014](#aos13527-bib-0018){ref-type="ref"}). This would allow leakage of fluid into the retina, creating the separation of retinal layers, and furthermore leading to the detachment of the retina. Surgical management by induction of a posterior vitreous detachment, with or without peeling of ILM, supports the hypothesis that traction is an imperative pathophysiological component (Hirakata et al. [2005](#aos13527-bib-0009){ref-type="ref"}, [2012](#aos13527-bib-0010){ref-type="ref"}; Rizzo et al. [2012](#aos13527-bib-0020){ref-type="ref"}; Avci et al. [2013](#aos13527-bib-0002){ref-type="ref"}), as does the reported spontaneous healing of macular detachment after posterior vitreous detachment (Bonnet [1991](#aos13527-bib-0004){ref-type="ref"}).

Low concentrations of *β*TP compared to normal CSF levels (Tumani et al. [1998](#aos13527-bib-0025){ref-type="ref"}; Reiber et al. [2003](#aos13527-bib-0019){ref-type="ref"}; Mase et al. [2003](#aos13527-bib-0016){ref-type="ref"}), as found in four of the five samples from the patients evaluated here, support this hypothesis. However, fluid from the vitreous space filtered through the retina as well as the existence of a direct passage into the retinal tissue through the pit, causing a RS, would have reduced the levels of the protein in the subretinal space. It also cannot be ruled out that due to the low elevation and small volume of the submacular detachment inhibited proper assessment of the protein levels in the fluid, either by dilution from vitreous fluid into the aspirate or incomplete drainage by the small‐gauge cannula. The presence of RS could also affect the accuracy of sampling of the SRF, making the exact origin of the fluid slightly uncertain in two of the four eyes with ODP. Furthermore, a potential source of bias when recording low protein concentrations is the possibility of proteolytic degradation with subsequent loss of antigenic determinants. These factors could then contribute to a spuriously low *β*TP in the aspirates, but we judge this to be at best a distant possibility.

The final case tested had an order of magnitude higher *β*TP, typical of CSF concentrations, which could indicate that in fact there was a direct conduit between the SRF to the subarachnoid space. However, given the presence of *β*TP in retinal and RPE cells, the higher concentration of the molecule may perhaps have originated from these cells and not CSF, leading to a false‐positive estimation. Also, the repeated analysis during the second operation in this patient was considerably lower than the first sample, indicating that the renewed SRF was similar to the levels found in the other three patient samples. It is a possibility that the larger cannula size in the final patient may have contributed to retinal damage resulting in an inaccurately high value of the protein in this case although the drainage of the SRF was successful.

Hence, the arguments for a false low *β*TP in the first three patients appear weaker to us than the arguments for an erroneously high *β*TP in patient 4. If so, this would favour the concept of optic pit fluid as a kind of low‐protein ultrafiltrate, in analogy with, for instance, renal cyst fluid. Although histopathological studies on ODP have found defects supporting passage between the optic disc anomaly and the subretinal space, a direct communication with the subretinal and subarachnoid spaces has to our knowledge not been confirmed (Christoforidis et al. [2012](#aos13527-bib-0006){ref-type="ref"}).

It is, however, possible that an uninterrupted pathway between these compartments exists in some of the patients with ODP, or alternatively that tractional forces from the posterior hyaloid as well as a communication between these spaces both contribute to the development of optic pit maculopathy. These explanations would nonetheless explain the variability between the two samples received from the final patient.

We conclude that, although our findings cannot differ definitively between the two alternative or synergistic pathophysiological explanations described previously, results so far indicate that the SRF in ODP is not identical to CSF, as the concentrations of *β*TP differ. Additional cases may resolve some of the open issues, and we advocate the assay of *β*TP or other biomarkers of CSF to be included in future studies of this condition. As little is known regarding the concentrations of *β*TP in the normal human vitreous and retina, in addition to other conditions where SRF is found, determination of *β*TP could be of value in research yet to come.

Ethical Approval {#aos13527-sec-0014}
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